Maraviroc Compassionate Use.

Trial Profile

Maraviroc Compassionate Use.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 06 May 2016

At a glance

  • Drugs Maraviroc (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors Pfizer; ViiV Healthcare
  • Most Recent Events

    • 10 Nov 2010 ViiV Healthcare added in associations field as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 10 Nov 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top